drugset / Trial / NCT04307173
Study of Multiple Ascending Dose of KBL693 in Healthy Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to investigate the safety and tolerability of KBL693 in healthy volunteers. KBL693 has been developed as a potential new treatment for moderate to severe asthma..
Timeline
- Start
- 2020-08-14
- Primary completion
- 2020-10-30
- Completion
- 2020-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KBL693 | Unknown | 680 mg | Oral |
| Subject | KBL693 | Unknown | 6800 mg | Oral |